US OptionsDetailed Quotes

JANX250516P17500

Watchlist

0.50
0.000.00%

15min DelayClose May 13 16:00 ET

0.00High0.00Low

Janux Therapeutics Stock Discussion

Jerry Kronenberg

May 7 04:30

Columns Wall Street Today: DJIA, S&P 500 and Nasdaq Composite All Shed Nearly 1%

The Dow industrials, Nasdaq Composite and S&P 500 all fell some 1% Tuesday as markets awaited Wednesday’s Federal Reserve interest-rate decision and brushed off the latest news in U.S. President Donald Trump’s tariff battles.
The $Dow Jones Industrial Average (.DJI.US)$ led the way downward in percentage terms, shedding 389.83 points (0.95%) to a 40,829 close. The $Nasdaq Composite Index (.IXIC.US)$ followed with a 154.58-poin...

The Fed kept interest rates unchanged again. Does it herald new market trends?

Teddy123

May 5 20:44

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

$Janux Therapeutics (JANX.US)$
Promising 7.5 Month PFS: JANX007 Expands to Earlier-Stage Prostate Cancer Treatment in Phase 1b Trial

74425369

Mar 10 19:40

INSIDER BUY ALERT: JANX

What happened: In recent weeks, $Janux Therapeutics (JANX.US)$ has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M.
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...

Kevin Travers

Dec 4, 2024 05:20

Columns Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today

After pulling back during the day, the S&P 500 and Nasdaq hit fresh closing highs- and the Nasdaq hit a trading high of 19,486.15.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.17%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.40%.
MACRO
JOLTS job openings from the Bureau of Labor Statistics came in at 7.74M, higher than last month's number, but ever since Ap...

Market eyes Non-Farm data: Will there be a rate cut in Dec?

Rivera

Dec 3, 2024 05:50

Up up

$Janux Therapeutics (JANX.US)$

Stock_Drift

Dec 3, 2024 05:45

After Hours Ticks 5:44pm 12/2

$CytomX (CTMX.US)$ $Onconetix (ONCO.US)$ $Edesa Biotech (EDSA.US)$ $XBP Europe Holdings (XBP.US)$ $Nauticus Robotics (KITT.US)$ $Alset (AEI.US)$ $Carmell (CTCX.US)$ $Jayud Global Logistics (JYD.US)$ $Vir Biotechnology (VIR.US)$ $Shimmick (SHIM.US)$ $Credo Technology (CRDO.US)$ $Janux Therapeutics (JANX.US)$ $Citius Oncology (CTOR.US)$ $Volato Group (SOAR.US)$
📊⚡️📊

103280143

Nov 18, 2024 21:51

A Glimpse into My 2025 Stock Picks (US Edition)

As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year.
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?

SpeedyStud

Nov 18, 2024 08:33

Mid Month Update

Hey everyone! Like I mentioned in the last post, the big news is that MoomooCA has set up a server for me, and it's open for all of you to join! It’s called Trader’s Tavern, and yes—the profile pic is my cat <3
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...

Shaaaw

Jun 25, 2024 20:07

Here’s why I think that $MRK buys $JANX soon.

$Merck & Co (MRK.US)$ on the prowl for acquisitions up to $15 billion.
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...

Rocketier (MAXN)

Jun 12, 2024 21:39

$Janux Therapeutics (JANX.US)$ we need some hype guys! 🚀

No comment yet